152 related articles for article (PubMed ID: 10831487)
1. Is placebo response the same as drug response in panic disorder?
Rapaport MH; Pollack M; Wolkow R; Mardekian J; Clary C
Am J Psychiatry; 2000 Jun; 157(6):1014-6. PubMed ID: 10831487
[TBL] [Abstract][Full Text] [Related]
2. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.
Pollack MH; Otto MW; Worthington JJ; Manfro GG; Wolkow R
Arch Gen Psychiatry; 1998 Nov; 55(11):1010-6. PubMed ID: 9819070
[TBL] [Abstract][Full Text] [Related]
3. Sertraline in the treatment of panic disorder: a double-blind multicenter trial.
Pohl RB; Wolkow RM; Clary CM
Am J Psychiatry; 1998 Sep; 155(9):1189-95. PubMed ID: 9734541
[TBL] [Abstract][Full Text] [Related]
4. Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
Pollack MH; Rapaport MH; Clary CM; Mardekian J; Wolkow R
J Clin Psychiatry; 2000 Dec; 61(12):922-7. PubMed ID: 11206597
[TBL] [Abstract][Full Text] [Related]
5. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
Pollack MH; Rapaport MH; Fayyad R; Otto MW; Nierenberg AA; Clary CM
J Psychiatr Res; 2002; 36(4):229-36. PubMed ID: 12191627
[TBL] [Abstract][Full Text] [Related]
6. Early coadministration of clonazepam with sertraline for panic disorder.
Goddard AW; Brouette T; Almai A; Jetty P; Woods SW; Charney D
Arch Gen Psychiatry; 2001 Jul; 58(7):681-6. PubMed ID: 11448376
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.
Mochcovitch MD; Nardi AE
Expert Rev Neurother; 2010 Aug; 10(8):1285-93. PubMed ID: 20662754
[TBL] [Abstract][Full Text] [Related]
8. Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation.
Londborg PD; Wolkow R; Smith WT; DuBoff E; England D; Ferguson J; Rosenthal M; Weise C
Br J Psychiatry; 1998 Jul; 173():54-60. PubMed ID: 9850204
[TBL] [Abstract][Full Text] [Related]
9. A placebo-controlled, randomized withdrawal study of sertraline for panic disorder in Japan.
Kamijima K; Kuboki T; Kumano H; Burt T; Cohen G; Arano I; Hamasaki T
Int Clin Psychopharmacol; 2005 Sep; 20(5):265-73. PubMed ID: 16096517
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies.
Sheikh JI; Londborg P; Clary CM; Fayyad R
Int Clin Psychopharmacol; 2000 Nov; 15(6):335-42. PubMed ID: 11110009
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study.
Bertani A; Perna G; Arancio C; Caldirola D; Bellodi L
J Clin Psychopharmacol; 1997 Apr; 17(2):97-101. PubMed ID: 10950471
[TBL] [Abstract][Full Text] [Related]
12. Two cases of panic disorder responsive to low-dose sertraline.
Orenstein H
Clin Neuropharmacol; 2010 Jul; 33(4):215-6. PubMed ID: 20661029
[No Abstract] [Full Text] [Related]
13. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
Simon NM; Otto MW; Worthington JJ; Hoge EA; Thompson EH; Lebeau RT; Moshier SJ; Zalta AK; Pollack MH
J Clin Psychiatry; 2009 Nov; 70(11):1563-70. PubMed ID: 19814948
[TBL] [Abstract][Full Text] [Related]
14. Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison.
Bandelow B; Behnke K; Lenoir S; Hendriks GJ; Alkin T; Goebel C; Clary CM
J Clin Psychiatry; 2004 Mar; 65(3):405-13. PubMed ID: 15096081
[TBL] [Abstract][Full Text] [Related]
15. Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder.
Lepola U; Arató M; Zhu Y; Austin C
J Clin Psychiatry; 2003 Jun; 64(6):654-62. PubMed ID: 12823079
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
Ballenger JC; Wheadon DE; Steiner M; Bushnell W; Gergel IP
Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
[TBL] [Abstract][Full Text] [Related]
17. Sertraline and alprazolam in the treatment of panic desorder.
Fiseković S; Loga-Zec S
Bosn J Basic Med Sci; 2005 May; 5(2):78-81. PubMed ID: 16053461
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies.
Clayton AH; Stewart RS; Fayyad R; Clary CM
Arch Womens Ment Health; 2006 May; 9(3):151-7. PubMed ID: 16292466
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder.
Liebowitz MR; Asnis G; Mangano R; Tzanis E
J Clin Psychiatry; 2009 Apr; 70(4):550-61. PubMed ID: 19358784
[TBL] [Abstract][Full Text] [Related]
20. Placebo response in the treatment of panic disorder.
Hirschfeld RM
Bull Menninger Clin; 1996; 60(2 Suppl A):A76-86. PubMed ID: 8857428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
